This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe
November 9–11, 2026
KoelnmesseCologne, Germany

The epicenter of the Business of Biotech

The intersection of capital, strategy, and deal-making. The Business of Biotech track zeroes in on the deals and investments driving the dynamics of the industry. With stories from inside the industry, this is the track where biotech leaders define what’s next.

Idea to execution. Handshake to launch. From the leaders who live it.

From shifting capital trends and the rise of AI to the growing influence of Asian markets, this track brings together the decision-makers shaping investment flows, M&A activity, and global partnerships across the industry.

See inside the biggest deals of 2026

The ‘unpacking the deal series takes a deep dive into the biggest deals of 2026. M&A or development partnership, hear from player who are part of deals like the Gilead/Tubulis acquisition. Every deal is different. Hear why directly from the players involved.

Show me the money

Early- or late-stage, public or private, hear from the investors who are driving the direction of biotech investment. The IPO window has finally opened but for how long? Can the innovation gap be closed? What kinds of companies can access alternative sources of financial resources?

Strategy for a global business

The biotech industry is suddenly facing uncertain business environments with new regional centers of strength and shifting commercial dynamics, all at the speed of light. Whether its day to day or planning for the long term, build your strategy hearing from the leaders

Personalized partnering strategy

A company needs to build a partnering approach that works for itself. Hear how companies have decided what to focus on, when to focus on what, and how to set out their own rules of engagement to drive programs forward.

Who should attend the Business of Biotech track?

C-level Leadership:

  • Founder
  • Chief Executive Officer (CEO)
  • Chief Financial Officer (CFO)
  • Chief Strategy Officer (CSO)
  • Chief Development Officer (CDO)
  • Chief Innovation Officer (CIO)

Senior Leaders in:

  • Business development
  • Corporate investment
  • Search and evaluation
  • Alliance management
  • Therapeutic area-specific partnering

How to attend

expand_more

All Access Partnering Pass

Full event access including one-to-one partnering meetings

Who this is for:
Ideal for companies actively seeking partnerships, licensing deals, or investment opportunities who want to schedule one-to-one meetings while accessing strategic program content and exclusive evening receptions.

This pass includes:
Access to partneringONE All program sessions All evening receptions Exhibit Hall Breakfast, Lunch and Refreshments at the venue

expand_more

Content-Only Pass

Program access only without meetings

Who this is for:
Designed for professionals focused on learning and strategic insights rather than active deal-making, offering deep-dive sessions on regulatory, clinical, manufacturing, market access, and commercialization strategies without one-to-one partnering meetings.

This pass includes:
All program sessions Monday Exhibit Hall Reception Exhibit Hall Breakfast, Lunch and Refreshments at the venue

More ways to participate
expand_more

More Ways to Participate

Beyond passes, explore opportunities to present, sponsor, and showcase your work

Present your company – Share your innovations with industry leaders [Learn more]

Sponsor or Exhibit– Elevate your brand visibility [Learn more]

Young Innovator – Special rates for emerging professionals [Learn more]

Academic Pass – Discounted access for researchers [Learn more]

Explore more content tracks at BIO-Europe

Discover additional specialized tracks designed to address every facet of biotech innovation and business development. Our tracks include: The Big Picture, The Business of Biotech, Regulatory Strategy, Therapeutic Insights. Biomanufacturing Strategy, Ecosystem Innovation and Clinical Strategy.